Diagnostic value of MRI-based PSA density in predicting transperineal sector-guided prostate biopsy outcomes.
Findlay MacAskillSu-Min LeeDavid Eldred-EvansWahyu WulaningsihRick PopertKonrad WolfeMieke Van HemelrijckGiles RottenbergSidath H LiyanagePeter AcherPublished in: International urology and nephrology (2017)
MR-PSAD may be better than total PSA in determining risk of positive biopsy outcome. Its use may improve risk stratification and reduce unnecessary biopsies.